Document:

ex10-5.htm

 

 

Exhibit 10.5

[OSI LETTERHEAD]

April 1, 2010

David Epstein

Senior Vice President, Oncology Research

Dear David:

It is my pleasure to confirm your promotion to Senior Vice President, Chief Scientific Officer, Oncology, effective today, of OSI Pharmaceuticals, Inc. (“OSIP”).  In this position you will now report to me.  The grade for this position is a 12. Your salary will remain the same.

In addition, in the event that there is a “Change in Control” of OSIP and within 12 months following such Change in Control either (a) your employment is terminated by OSIP (or a successor) without “Cause” or (b) you terminate your employment with “Good Reason” (terminations following a Change in Control described in clause (a) or (b) being referred to herein as a “Severance”),  the vesting of all unvested equity or equity based awards held by you at the time of such Severance, including stock options and RSU’s and, for the avoidance of doubt, any equity,  equity-based awards or other benefits of either OSIP or a successor into which unvested equity of OSIP held by you at the time of a Change in Control is converted in connection with the Change in Control, will accelerate and be immediately exercisable or payable, as the case may be, immediately prior to such Severance.   This provision supersedes the provisions regarding the same subject in the agreements evidencing your grants of stock options and RSU’s made in December 2009.

For purposes of this letter agreement, the terms Change in Control, Cause and Good Reason (and the defined terms included in such definitions) shall have the meaning set forth on Appendix A hereto. In the event that any of the payments referenced herein must be delayed so as to avoid the imposition of additional taxes upon you pursuant to the operation of Section 409A of the Internal Revenue Code of 1986, as amended, such payments shall be delayed until the date which is six months and one day following a Severance.

  

  

  

David, I congratulate you on this achievement and trust you will meet the challenges of your new position with great success.  If you are in agreement with this letter, please sign both copies of this letter and return one copy to Amy Sheehan in the enclosed envelope.  One copy is for your records.

Sincerely,

/s/ Colin Goddard

Colin Goddard, Ph.D.

Chief Executive Officer

 

 

	
Accepted by:

	
/s/ David Epstein

	  
	  	
David Epstein

	  

Date: _______________________

  

  

  

 

APPENDIX A – APPLICABLE DEFINITIONS

“Affiliate” shall mean, with respect to any individual or entity, any other individual or entity who, directly or indirectly through one or more intermediaries, controls, is controlled by or is under common control with, such individual or entity.

“Board” shall mean the Board of Directors of OSIP.

"Cause" shall mean that you have: (a) willfully and continually failed to substantially perform, or been willfully grossly negligent in the discharge of, your duties to OSIP or any of its subsidiaries (in any case, other than by reason of a disability, physical or mental illness or analogous condition), which failure or negligence continues for a period of 10 business days after a written demand for performance is delivered to you by the Board, which specifically identifies the manner in which the Board believes that you have not substantially performed, or been grossly negligent in the discharge of, his or her duties; (b) committed or engaged in an act of theft, embezzlement or fraud, or committed a willful and material breach of confidentiality with respect to OSIP or any of its subsidiaries or a willful unauthorized disclosure or use of inside information, customer lists, trade secrets or other confidential information of OSIP or any of its subsidiaries; (c) willfully breached a fiduciary duty, or willfully and materially violated any other duty, law, rule, regulation or policy of OSIP or any of its subsidiaries; or (d) been convicted of a felony or a misdemeanor with respect to which fraud or dishonesty is a material element.  No act or failure to act on your part shall be deemed "willful" unless done, or omitted to be done, by you not in good faith or without reasonable belief that your act or failure to act was in the best interests of OSIP.

A "Change in Control" shall be deemed to mean the first of the following events to occur after the date hereof:

(a)           The acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act (a "Person")) of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 50% or more of either (1) the then-outstanding shares of common stock of OSIP (the "Outstanding Company Common Stock") or (2) the combined voting power of the then-outstanding voting securities of OSIP entitled to vote generally in the election of directors (the "Outstanding Company Voting Securities"); provided, however, that, for purposes of this clause (a), the following acquisitions shall not constitute a Change in Control; (A) any acquisition directly from OSIP, (B) any acquisition by OSIP, (C) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by OSIP or any Affiliate of OSIP or a successor, or (D) any acquisition by any entity pursuant to a transaction that complies with clause (c)(1) or (c)(2) below;

(b)           Individuals who, as of the date hereof, constitute the Board (the "Incumbent Board") cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the date hereof whose election, or nomination for election by OSIP's shareholders, was approved by a vote of at least two-thirds of

  

  

  

the directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board;

(c)           The consummation of a merger or consolidation of OSIP or any direct or indirect subsidiary of OSIP with any other corporation, other than (1) a merger or consolidation which results in the directors of OSIP immediately prior to such merger or consolidation continuing to constitute at least a majority of the board of directors of OSIP, the surviving entity or any parent thereof or (2) a merger or consolidation effected to implement a recapitalization of OSIP (or similar transaction) in which no Person acquires beneficial ownership, directly or indirectly, of securities of OSIP (not including in the securities beneficially owned by such Person any securities acquired directly from OSIP) representing 50% or more of the Outstanding Company Common Stock or the Outstanding Company Voting Securities; or

(d)           Shareholders of OSIP approve a plan of complete liquidation or dissolution of OSIP or there is consummated an agreement for the sale or disposition by OSIP of all or substantially all of OSIP 's assets, other than a sale or disposition by OSIP of all or substantially all of OSIP 's assets to an entity, at least 50% of the combined voting power of the voting securities of which are owned by shareholders of OSIP in substantially the same proportions as their ownership of OSIP immediately prior to such sale.

“Exchange Act” shall mean the Securities Exchange Act of 1934, as amended.

“Good Reason” shall mean (i) a material adverse alteration in the nature or status of your responsibilities with OSIP or any subsidiary thereof from those in effect immediately prior to the Change in Control, (ii) a reduction in your salary or target bonus opportunity from those in effect immediately prior to the Change in Control, or (iii) a relocation of your principal place of business of more than 35 miles; provided that the relocation of your work location to Ardsley, New York which is planned as of the date hereof shall not constitute Good Reason hereunder.ex10-6.htm

 

 

Exhibit 10.6

 

 

[OSI LETTERHEAD]

 

 

August 17th, 2009.

 

Dr. Angela Davies

Sr. Director, Clinical Development

 

Dear Angela,

 

I want to thank you for sharing your thoughts and observations with me in our recent conversations.  I appreciate both your input and your candor and, as I hope I have successfully communicated to you, I am convinced that you have the potential to enjoy a long and successful career in a leadership role here at OSI.  In accord with our discussion this past Saturday – and contingent upon you committing to join us at our new campus in Ardsley – I am delighted to offer you the following:

 

	
  

	
·

	
A promotion to Vice-President of Clinical Research – Oncology, initially reporting to Dr. Karsten Witt, Interim Head of Oncology Development.  The position will be at Grade 10 and carries an annual bonus target of 30% base salary;

	
  

	
·

	
Your annual salary will be increased to $330,000, less taxes. This comprises the 5% commitment increase noted in the letter you received in July and an additional promotional increase;

	
  

	
·

	
Membership of the OSI Executive Management Committee;

	
  

	
·

	
A commitment bonus equal to 6 months salary and a relocation package as previously communicated to you in the July letter; and,

	
  

	
·

	
You will receive a lump sum equal to $80,000 less taxes to assist you with your relocation expenses.  This amount may be requested after you commit to join OSI at the new Ardsley campus by submitting a letter in writing to Human Resources requesting payment.  If you voluntarily resign from the Company within 2 years from the time you receive your payment you will be required to re-pay 100% of the amount that was given to you.

 

These changes to your salary, title, grade and EMC membership will be effective immediately upon your acceptance of the offer and its contingent commitment to the Ardsley relocation.  Also, and as we discussed, should you choose to commit in a timely fashion, I will be happy to invite you to join us at the annual EMC strategy retreat scheduled for September 1st-4th in Oxford, UK.  This will be a terrific opportunity for you to come up to speed as our newest EMC member.

 

Angela, I'd be honored to have you choose to continue your career with us in Ardsley and I am convinced that you will have a lot to offer as we embark upon the next exciting chapter in the company's journey.  Should you be willing to do so please let me know as soon as possible and

 

 

  

  

  

 

acknowledge your acceptance of the offer described herein by signing below and returning to Linda Amper.

 

Sincerely,

 

/s/ Colin Goddard

 

Colin Goddard,

Chief Executive Officer

 

Acknowledgement:

 

	
/s/ Angela Davies

	  
	
Dr. Angela Davies

	  

 

 

2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00171-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00171-of-00352.parquet"}]]